More about

Allogeneic Transplantation

News
January 12, 2022
2 min read
Save

Survival rate rises steadily among patients with relapsed ALL after stem cell transplant

The 2-year OS rate nearly doubled during the past 2 decades among patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who relapsed after allogeneic hematopoietic stem cell transplantation, according to study results.

News
December 17, 2021
3 min watch
Save

VIDEO: Inotuzumab ozogamicin shows ‘encouraging’ results in high-risk ALL population

Inotuzumab ozogamicin was well tolerated among patients with acute lymphoblastic leukemia who had undergone allogenic transplantation in a small study.

News
December 17, 2021
1 min watch
Save

VIDEO: New data on allogeneic CAR T-cells

In this video, Joshua Sasine, MD, PhD, assistant professor of medicine hematology and cellular therapy at Samuel Oschin Cancer Center Regenerative Medicine Institute, discusses new allogeneic chimeric antigen receptor T-cell therapy data.

News
December 15, 2021
2 min read
Save

FDA approves Orencia for prevention of acute GVHD

The FDA approved abatacept in combination with a calcineurin inhibitor and methotrexate for prevention of acute graft versus host disease.

News
September 22, 2021
1 min read
Save

FDA approves Jakafi for chronic GVHD

The FDA approved ruxolitinib for treatment of certain patients with chronic graft-versus-host disease.

News
August 16, 2021
3 min read
Save

Post-transplant cyclophosphamide increases risk for early cardiac events

Post-transplant cyclophosphamide reduced incidence of graft-versus-host disease but led to higher incidence of early cardiac events after allogeneic hematopoietic stem cell transplantation, according to study results.

News
July 17, 2021
5 min read
Save

Role of allogeneic HSCT fading in lymphoma management

As targeted therapies and novel treatments emerge, allogeneic hematopoietic cell transplantation has taken a backseat to immunotherapy in the treatment of lymphoma.

News
July 13, 2021
1 min read
Save

Bone marrow transplant specialist joins Fox Chase

Peter Abdelmessieh, DO, MSc, has joined the department of bone marrow transplant and cellular therapies at Fox Chase Cancer Center.

News
June 24, 2021
2 min watch
Save

VIDEO: Allogeneic transplant shows potential in high-risk multiple myeloma

Allogeneic hematopoietic cell transplantation showed potential in patients with high-risk multiple myeloma, according to findings presented at the ASCO Annual Meeting.

News
February 22, 2021
1 min read
Save

FDA grants priority review to Jakafi for chronic GVHD

The FDA granted priority review to ruxolitinib for the treatment of adults and children aged 12 years or older with steroid-refractory chronic graft-versus-host disease, according to a manufacturer-issued press release.

View more